UK Core Implementation Guide 1.0.0 - STU1

vaccineCode

Vaccine that was administered or was to be administered.

This indicates vaccine product administered. This SHOULD be a dm+d code from ValueSet UKCore-VaccineCode. AMPP codes SHOULD NOT be used.


Table View

Immunization.id[0]UKCore-Immunization-Sn-AstraZenecaVaccine-Example
Immunization.status[0]completed
Immunization.vaccineCode[0].coding[0].system[0]https://dmd.nhs.uk
Immunization.vaccineCode[0].coding[0].code[0]39114911000001105
Immunization.vaccineCode[0].coding[0].display[0]COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)
Immunization.patient[0].reference[0]Patient/UKCore-Patient-RichardSmith-Example
Immunization.occurrenceDateTime[0]2021-07-20

Tree View

Immunization

XML View

<Immunization xmlns="http://hl7.org/fhir">
    <id value="UKCore-Immunization-Sn-AstraZenecaVaccine-Example" />
    <status value="completed" />
    <!--  **************snippet start**************  -->
    <vaccineCode>
        <coding>
            <system value="https://dmd.nhs.uk" />
            <code value="39114911000001105" />
            <display value="COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" />
        </coding>
    </vaccineCode>
    <!--  **************snippet end**************  -->
    <patient>
        <reference value="Patient/UKCore-Patient-RichardSmith-Example" />
    </patient>
    <occurrenceDateTime value="2021-07-20" />
</Immunization>

JSON View

{
    "resourceType": "Immunization",
    "id": "UKCore-Immunization-Sn-AstraZenecaVaccine-Example",
    "status": "completed",
    "vaccineCode": {
        "coding":  [
            {
                "system": "https://dmd.nhs.uk",
                "code": "39114911000001105",
                "display": "COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)"
            }
        ]
    },
    "patient": {
        "reference": "Patient/UKCore-Patient-RichardSmith-Example"
    },
    "occurrenceDateTime": "2021-07-20"
}


back to top